Literature DB >> 20816939

Investigation of riboflavin sensitized degradation of purine and pyrimidine derivatives of DNA and RNA under UVA and UVB.

Prakash C Joshi1, Thomas C Keane.   

Abstract

DNA and RNA undergo photodegradation in UVC (200-290nm) due to direct absorption by the purine and pyrimidine bases. Limited effects are observed under UVB (290-320nm) or UVA (320-400nm). We have observed that an endogenous photosensitizer, riboflavin (RF), upon exposure to UVB or UVA can extensively damage the DNA and RNA bases. Guanine, uracil, thymine, adenine and cytosine were degraded by 100%, 82%, 60.4%, 46.3% and 10.3% under UVA (12J) and by 100%, 54.1%, 38.9%, 42.2% and <1.0% under UVB (6J), respectively. Guanosine and deoxyguanosine were degraded by 98±1.0% and 80±1.0% under UVA (4J) and UVB (12J), respectively. With an exception of GMP (53-82%), dGMP (51-88%) and to some extent TMP (3-4%) the remaining nucleosides and nucleotides were resistant to RF-induced photodecomposition. The photodegradation of G derivatives by RF was 2-fold higher than a well known photodynamic agent rose bengal. A comparison of the intensities of UVA and UVB sources used in this study with natural sunlight suggests that exposure with the latter along with an endogenous photosensitizer can have similar effects on DNA and RNA depending upon the duration of exposure.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816939     DOI: 10.1016/j.bbrc.2010.08.138

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  UVA irradiation of riboflavin generates oxygen-dependent hydroxyl radicals.

Authors:  Saadettin Sel; Norbert Nass; Sandy Pötzsch; Stefanie Trau; Andreas Simm; Thomas Kalinski; Gernot Iw Duncker; Friedrich E Kruse; Gerd U Auffarth; Hans-Jürgen Brömme
Journal:  Redox Rep       Date:  2013-11-20       Impact factor: 4.412

Review 2.  Riboflavin Has Neuroprotective Potential: Focus on Parkinson's Disease and Migraine.

Authors:  Eyad T Marashly; Saeed A Bohlega
Journal:  Front Neurol       Date:  2017-07-20       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.